The impact of chemotherapy after pediatric malignancy on humoral immunity to vaccine-preventable diseases
Conclusions: We confirm that seroprotection for vaccine-preventable diseases is affected by treatment for pediatric malignancy. A single booster dose of vaccine might be a practical way to restore vaccine immunity in patients after chemotherapy.
Source: Mediterranean Journal of Hematology and Infectious Diseases - Category: Hematology Authors: Chiara Garonzi, Rita Balter, Gloria Tridello, Anna Pegoraro, Manuela Pegoraro, Monia Pacenti, Novella Scattolo, Simone Cesaro Source Type: research
More News: Cancer & Oncology | Chemotherapy | Hematology | Hepatitis | Hepatitis B | Hepatitis Vaccine | Infectious Diseases | Measles | Measles Vaccine | Mumps | Mumps Vaccine | Pediatrics | Pneomococcal Vaccine | Pneumonia | Rubella | Rubella Vaccine | Vaccines | Varicella-Zoster Virus Vaccine